Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study.

ABSTRACT:

SUBMITTER: Roster K 

PROVIDER: S-EPMC11748953 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature